
Tenax Therapeutics
Tenax Therapeutics maintains an oxygen supply to stop disease and damage to tissues that occurs when the flow of oxygen is interrupted.
Market cap
$24.3m
Enterprise value
$15m
Share price
$5.76 TENX
Authorizing premium user...
Tenax Therapeutics maintains an oxygen supply to stop disease and damage to tissues that occurs when the flow of oxygen is interrupted.